A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release

Outside experts said the data, provided by press release, were too limited to draw conclusions, though they hoped that colchicine, a generic medicine with manageable side effects, would prove to be beneficial for Covid-19.